If you live in Alabama and are researching compounded GLP-1 medications for weight management, this page is meant to save you a few hours. It covers how telehealth access works under Alabama’s rules, what the state’s medical and pharmacy boards have said about compounded semaglutide and tirzepatide, what these medications actually cost from providers that publish their prices, and answers to the questions Alabamians ask most. Alabama’s telehealth law is more specific than most states’, so the rules section is worth reading even if you skim the rest.
One disclosure up front: this site is operated by Gentle Health, a telehealth provider of compounded GLP-1 medications. We appear in the comparison table below on the same terms as everyone else, and we link to every source so you can check our work.
How compounded GLP-1 access works in Alabama
Alabama allows physicians to evaluate and treat patients by telehealth, provided the physician holds a full, active Alabama medical license. Since 2022, the state no longer offers a special limited license for out-of-state telehealth doctors; a physician either holds a real Alabama license or does not practice on Alabama patients.
At Gentle Health, care for Alabama patients is provided by James Simmons, MD, who is licensed in Alabama through the Interstate Medical Licensure Compact (license 54547, state board record), the multi-state agreement that lets qualified physicians obtain full licenses in member states, of which Alabama is one.
The full list of states we serve, with each license number and its board-verification link, is on our states page.
Whether an Alabama patient begins with an asynchronous review or a scheduled video visit is covered in how our initial prescribing process varies by state.
The process works like this:
- You complete an online health intake covering your medical history, current medications, and goals.
- Dr. Simmons reviews your intake and conducts a telehealth evaluation. Alabama law requires that the patient initiate this relationship, that the physician verify your identity and location, and that you consent to receiving care by telehealth; all of that happens during onboarding.
- If treatment is appropriate, Dr. Simmons writes a prescription. Not everyone is a candidate, and a prescription is never guaranteed.
- Your medication is prepared by a licensed compounding pharmacy and shipped to your Alabama address.
- Follow-up happens through scheduled check-ins with Dr. Simmons, who adjusts dosing over time.
There is no clinic to drive to and no waiting room. That said, Alabama places some specific conditions on ongoing telehealth care, covered next.
Alabama rules worth knowing
Alabama went from having some of the more restrictive telehealth rules in the country to a defined statutory framework with Act 2022-302, signed in April 2022 and effective July 11, 2022. A few of its provisions matter directly to GLP-1 patients.
A full Alabama license is required. The law repealed Alabama’s special-purpose telehealth license. Any physician treating Alabama patients by telehealth must hold a full, active Alabama medical license, per the Medical Association of the State of Alabama’s explainer on the law. If an online provider cannot tell you the name and Alabama license status of the physician treating you, that is a red flag.
No in-person visit is needed to start care. A physician-patient relationship may be established by telehealth, as long as the patient initiates it. Physicians may prescribe non-controlled legend drugs, including GLP-1 medications, via telehealth once a legitimate medical purpose is established. The stricter requirement (a prior in-person visit within 12 months) applies only to controlled substances, per Burr & Forman’s summary of the law. Semaglutide and tirzepatide are not controlled substances.
The four-visit rule. This is the provision most relevant to ongoing care. If a physician or practice group sees the same patient for the same condition by telehealth more than four times in 12 months without resolution of the problem, the physician must either see the patient in person within 12 months or refer the patient to another physician for an in-person visit. The in-person requirement can also be satisfied via telehealth if a licensed physician or nurse is physically with the patient. There are exceptions, including when the telehealth physician is in active consultation with a physician providing in-person care, and the Board of Medical Examiners can create further exemptions by rule. If you are on a long-term telehealth GLP-1 program in Alabama, it is reasonable to ask your provider how their visit cadence accounts for this rule.
The boards have been vocal about compounded GLP-1s. The Alabama Board of Medical Examiners issued a consumer alert about the GLP-1 boom, and it names specific problems: some physician offices compounding semaglutide in-office from salt forms or research-grade powder that do not meet federal requirements, online programs conducting minimal evaluations with no follow-up, and out-of-state pharmacies offering doctors kickbacks per prescription. The alert, which followed the FDA’s July 2023 warning about compounded semaglutide, notes the Alabama Board of Pharmacy told licensees that using semaglutide salts or any non-pharmaceutical-grade active ingredient is prohibited, and that at the time of that alert the Board was not aware of any Alabama-permitted compounding pharmacy sourcing pharmaceutical-grade semaglutide API. The Board has not published a more recent public statement on that point that we could find, so treat it as a reason to ask sourcing questions rather than a current census of the market. In a separate declaratory ruling, the Board of Medical Examiners stated that physicians compounding GLP-1 products must comply with USP standards and purchase ingredients only from entities permitted by the Alabama Board of Pharmacy.
The practical takeaway for patients: in Alabama, the question is not just “can I get compounded semaglutide?” but “is the pharmacy behind it licensed and properly sourced?” Ask any provider, including us, which pharmacy fills the prescription, whether it holds an Alabama Board of Pharmacy permit, and whether the active ingredient is the base form from an FDA-registered facility. Compounded medications are not FDA-approved, and the FDA has documented specific concerns about improperly sourced GLP-1 products, which is exactly why sourcing questions are fair game.
Compounded semaglutide in Alabama
Semaglutide is a GLP-1 receptor agonist. It mimics a hormone your body produces after eating, which slows stomach emptying, moderates appetite signaling in the brain, and helps regulate blood sugar. Compounded semaglutide is a version of the medication prepared by a licensed compounding pharmacy under a physician’s prescription for an individual patient. It is not an FDA-approved product, and it is not interchangeable with brand-name GLP-1 medications.
For Alabama patients, Gentle Health offers compounded semaglutide in two forms:
- Oral compounded semaglutide: starting at $112 per month. A daily form for patients who prefer not to inject.
- Injectable compounded semaglutide: starting at $135 per month. A once-weekly subcutaneous injection, the format used in most clinical practice.
Pricing is dose-tiered cash-pay. It changes when your prescribed dose moves into a different tier, there are no membership fees layered on top, and we do not bill insurance. Treatment always begins with a medical evaluation by James Simmons, MD, and continues only if he determines it is appropriate for you.
Compounded tirzepatide in Alabama
Tirzepatide works on two receptors rather than one: GLP-1 and GIP, a second gut hormone involved in metabolism. Like compounded semaglutide, compounded tirzepatide is prepared by a licensed compounding pharmacy for an individual patient under prescription, and it is not an FDA-approved product.
Gentle Health offers compounded tirzepatide to Alabama patients starting at $169 per month, cash-pay, with the same dose-tiered structure: published prices for each prescribed dose tier, no membership fee, no insurance involvement. Whether semaglutide or tirzepatide is the better starting point for you is a clinical decision that Dr. Simmons makes with you during your evaluation, based on your history, your tolerance considerations, and your goals.
Provider options in Alabama: comparison table
Methodology: providers listed alphabetically, not ranked; prices were taken only from each provider’s public web pages on July 27, 2026, and where a provider does not publish a price we say so rather than guess.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves Alabama | Insurance | Source |
|---|---|---|---|---|---|---|
| Alabama Sleep & Lung Medicine (Homewood, AL) | In-person clinic, Birmingham area; states it serves patients across the Southeast | $150 per month of starting-dose shots ($37.50/shot at 0.25 mg; higher doses may differ) | From $250 | Yes (Alabama-based) | Visits may be billed to insurance; clinic asks patients to confirm coverage | alsleeplungmed.com (verified 2026-07-27) |
| Dr. Medical Health | National telehealth | From $199 | From $299 | Yes (lists all 50 states) | No insurance; accepts cards, HSA, FSA | drmedhealth.com (verified 2026-07-27) |
| Gentle Health (operates this site) | Telehealth; care by James Simmons, MD | From $112 oral / from $135 injectable | From $169 | Yes | Cash-pay only; no insurance | gentle.health (verified 2026-07-27) |
| Mochi Health | Telehealth marketplace; affiliated physician practices | $99 plus $79/mo membership | From $199 plus $79/mo membership | Yes (Alabama address listed on its locations page as of July 2026) | Medication is cash-pay; membership required | joinmochi.com (semaglutide verified 2026-07-30; tirzepatide 2026-07-27) |
| Sanctuary Wellness Institute | Telehealth; serves Birmingham, Huntsville, Mobile, Montgomery and statewide | $225 first month, $275/mo after (flat program rate incl. consults, labs, medication) | See site | Yes | Cash-pay program rate | sanctuarywellnessinstitute.com (verified 2026-07-27) |
Two notes on reading this table fairly. First, the structures differ: some providers quote a bare medication price with a separate membership, some quote an all-in program rate, and some charge more as your dose increases, so the cheapest headline number is not always the cheapest year. Second, some large national telehealth companies do not appear here because their Alabama availability could not be confirmed: third-party coverage (Forbes Health) reports that Henry Meds, for example, does not serve Alabama, and Henry’s own site does not publish a state list, so check its signup flow directly if you are considering it. Provider availability in Alabama changes more often than in most states.
For a year-long, all-fees-included view of how the major programs price out, see our full comparison of what GLP-1 programs actually cost.
Frequently asked questions
Is compounded semaglutide legal in Alabama?
Compounded medications are legal under federal and Alabama law when prepared by a properly licensed pharmacy, from properly sourced ingredients, under a valid patient-specific prescription. Alabama’s boards have been explicit that compounding from semaglutide salts or non-pharmaceutical-grade ingredients is prohibited, and physicians must source only from pharmacies and suppliers permitted by the Alabama Board of Pharmacy. Legality in practice depends on the pharmacy behind your prescription, so ask.
Do I need to see a doctor in person to get a GLP-1 prescription in Alabama?
Not to start. Alabama’s telehealth law allows a physician-patient relationship to be established by telehealth for non-controlled medications, which includes semaglutide and tirzepatide. However, Alabama’s four-visit rule means that after more than four telehealth visits in 12 months for the same unresolved condition, your physician must see you in person or arrange an in-person referral. Ask any telehealth provider how they handle this.
Who provides care at Gentle Health for Alabama patients?
James Simmons, MD, who holds an Alabama medical license obtained through the Interstate Medical Licensure Compact. Every Alabama patient’s evaluation, prescription decision, and follow-up care runs through him, not a rotating cast.
Does insurance cover compounded GLP-1s in Alabama?
Generally no. Insurance plans, including Alabama Medicaid and most Blue Cross and Blue Shield of Alabama plans, do not cover compounded medications, which is why cash pricing matters so much in this category. Gentle Health is cash-pay only, with starting prices of $112 per month for oral compounded semaglutide, $135 for injectable, and $169 for compounded tirzepatide.
Can I fill a compounded GLP-1 prescription at my local Alabama pharmacy?
Usually not. Compounded semaglutide and tirzepatide come from compounding pharmacies, which are a small subset of pharmacies, and Alabama’s Board of Pharmacy has flagged sourcing problems in this category. Most telehealth providers, Gentle Health included, ship from a licensed compounding pharmacy directly to your home.
Why don’t some big national telehealth companies serve Alabama?
Alabama requires a full state medical license for telehealth, applies the four-visit rule to ongoing virtual care, and its Board of Pharmacy polices compounded GLP-1 sourcing closely. Not every national provider serves every state, and coverage maps in this category change frequently, so check the provider’s own site for current availability.
What should I ask before choosing a compounded GLP-1 provider in Alabama?
Four things: the name and Alabama license status of the physician who will treat you, the name and permit status of the compounding pharmacy, the all-in monthly cost including any membership fees and dose increases, and how the provider handles Alabama’s in-person visit rule for ongoing care.
Current Gentle Health dose tiers and pricing
Gentle Health pricing depends on the dose tier prescribed by your clinician. Current monthly prices are:
Oral compounded semaglutide
| Tier | Daily dose | Monthly price |
|---|---|---|
| Starting | 2-4 mg/day | $112/mo |
| Medium | >4-8 mg/day | $189/mo |
| High dose | >8-12 mg/day | $258/mo |
Injectable compounded semaglutide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 0.24-0.48 mg/wk | $135/mo |
| Medium | >0.48-1.2 mg/wk | $159/mo |
| High dose | >1.2-2.4 mg/wk | $199/mo |
Injectable compounded tirzepatide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 2.5-5 mg/wk | $169/mo |
| Medium | >5-10 mg/wk | $219/mo |
| High dose | >10-15 mg/wk | $269/mo |
Medication, the initial review by a licensed clinician, video visits and messaging, and overnight refrigerated shipping are included. There is no separate membership fee, and HSA and FSA cards are accepted. Your clinician determines the appropriate medication and dose; the monthly price changes if the prescribed dose moves into a different tier.
Gentle Health serves patients across a growing multistate footprint through clinicians licensed in each patient’s jurisdiction, including Alabama.
Reviewed by James Simmons, MD
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.